Skip to main content

Find Clinical Trials

Home
Conditions
Advanced Triple-Negative Breast Cancer

Clinical trial condition

Advanced Triple-Negative Breast Cancer

Explore clinical trials studying Advanced Triple-Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Advanced Triple-Negative Breast Cancer trial results

Not yet recruiting

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

NCT07581314

Conditions: Advanced Triple-Negative Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer

NCT07367178

Conditions: Advanced HR+/HER2- Breast Cancer, Advanced Triple-Negative Breast Cancer, Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Completed

A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer

NCT06685796

Conditions: Advanced Triple-Negative Breast Cancer
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Completed

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

NCT03254654

Conditions: Advanced Triple-Negative Breast Cancer
Locations: Fudan University Cancer Hospital Shanghai, China

View Trial Details